Full Press Release Details
Biogen Issues First Progress Report of its Signature Healthy Climate, Healthy Lives™ Initiative.
BIIB
Biogen Issues First Progress Report of its Signature Healthy Climate, Healthy Lives™ Initiative
Key Takeaway: Biogen Issues First Progress Report of its Signature Healthy Climate, Healthy Lives™ Initiative
Price reaction · baseline $289.32 (2021-09-22 close) · hit after-hours · 1 other BIIB headline(s) in the window, move may be shared
day 0 close
+1.3%
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+34%
120-day peak, hindsight
Typical move
1.8%
average across 15 past catalysts
Lead asset
Alefacept
Phase 3 · Chronic Plaque Psoriasis